The use of medications during pregnancy is a significant concern for healthcare professionals, pregnant women and society as a whole. The impact of drug use on fetal development can be profound and long-lasting, leading to a range of birth disabilities, developmental disorders and other health problems. Pregnant women who use drugs, whether prescription drugs, over-the-counter drugs, or illicit substances, expose their unborn children to a variety of risks that can have serious consequences. The developing fetus is particularly vulnerable to the effects of medications because its organs and systems are at crucial stages of development. Drug use can interfere with normal growth and maturation processes, potentially leading to lifelong complications. The dangers associated with drug use during pregnancy are well documented and highlight the importance of education, support and intervention for pregnant women. One of the most concerning aspects of drug use during pregnancy is the risk of congenital disabilities. Some medications can cause structural abnormalities in the developing fetus, affecting organs such as the heart, brain and limbs. For example, the use of certain antiepileptic drugs has been linked to an increased risk of neural tube defects, which are serious abnormalities of the brain and spinal cord. Similarly, alcohol use during pregnancy can lead to fetal alcohol spectrum disorder (FASD), which encompasses a range of physical, behavioral, and cognitive impairments. These conditions can lead to lifelong challenges for those affected, highlighting the critical need for pregnant women to avoid substance use. Besides congenital disabilities, drug use during pregnancy can also lead to developmental and behavioral disorders. Exposure to medications in utero can disrupt brain development, leading to problems such as attention deficit hyperactivity disorder (ADHD), learning disabilities, and emotional disorders. Infants exposed to drugs like cocaine or methamphetamine may be born with withdrawal symptoms, a condition known as neonatal abstinence syndrome (NAS). These newborns may experience tremors, irritability, feeding difficulties, and breathing problems. The long-term effects of prenatal drug exposure can manifest as academic difficulties, social challenges, and increased risk of substance abuse later in life. This highlights the importance of early intervention and support for children affected by prenatal drug exposure. Another important concern is the impact of drug use on maternal health during pregnancy. Pregnant women who use drugs are at higher risk of complications such as premature labor, placental abruption and infections. These complications can have serious consequences for both the mother and the baby. For example, premature birth is associated with a range of health problems, including respiratory distress syndrome, jaundice and increased susceptibility to infections. Placental abruption, where the placenta separates prematurely from the uterine wall, can lead to severe bleeding and compromise the baby's supply of oxygen and nutrients. Additionally, drug use can